SPDR Advertisement SureTrader SureTrader SPDR Advertisement
Home > Boards > US Listed > Miscellaneous > Rigel Pharmaceuticals Inc. (RIGL)

7:40AM On The Wires (WIRES) :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 440
Posts 21,999
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Advertisement
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2015 5:53:55 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/1/2015 5:47:37 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/1/2015 4:18:12 PM
Rigel Welcomes Keith A. Katkin to Board of Directors "PR Newswire (US)" - 6/30/2015 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/12/2015 7:23:41 PM
Rigel to Present at Jefferies 2015 Global Healthcare Conference "PR Newswire (US)" - 5/28/2015 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/15/2015 5:21:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/14/2015 6:38:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/14/2015 6:38:12 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/14/2015 6:37:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/14/2015 6:36:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/14/2015 6:27:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/7/2015 4:51:59 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 5/7/2015 4:48:30 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/7/2015 4:32:29 PM
Rigel Announces First Quarter 2015 Financial Results "PR Newswire (US)" - 5/7/2015 4:05:00 PM
Zacks Reaffirms "Buy" Rating for Rigel Pharmaceuticals (RIGL) "Analyst Ratings Network" - 5/1/2015 8:15:37 PM
Rigel Announces Conference Call and Webcast to Report First Quarter 2015 Financial Results and Pipeline Update "PR Newswire (US)" - 4/30/2015 7:30:00 AM
Why Rigel Pharmaceuticals Shares Surged Higher Today "The Motley Fool" - 3/31/2015 5:27:36 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 3/30/2015 5:06:31 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/30/2015 4:59:36 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 3/18/2015 5:30:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/3/2015 4:07:38 PM
surf1944   Friday, 05/06/11 09:58:11 AM
Re: surf1944 post# 130
Post # of 331 
7:40AM On The Wires (WIRES) :

Rigel Pharmaceuticals, Inc. (RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer (PFE) is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D. Rigel is evaluating the details of R343's development to date and expects to design a Phase 2 clinical trial with R343 later this year.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist